Related Experiment Video

Updated: Aug 20, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

p53-R175H mutant gains new function in regulation of doxorubicin-induced apoptosis

Wing-pui Tsang1, Franz Y F Ho, Kwok-pui Fung

  • 1Department of Biochemistry, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.

International Journal of Cancer
|December 4, 2004
PubMed

Insights

Mutant p53 (R175H) hinders cancer cell death by suppressing caspase-3 activation. Restoring p53 function re-sensitizes cells to chemotherapy, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p53 tumor suppressor gene plays a critical role in regulating apoptosis, the programmed cell death crucial for eliminating damaged cells.
  • Mutations in p53 can lead to altered protein function, potentially promoting cancer development and resistance to therapy.
  • Understanding how specific p53 mutations affect cellular responses to DNA damage is vital for improving cancer treatment strategies.

Purpose of the Study:

  • To investigate the functional impact of the p53 R175H mutation on apoptosis induction in cancer cells.
  • To explore the role of caspase-3 activation in the altered apoptotic response mediated by p53 R175H.
  • To assess the potential of targeting the mutant p53 R175H for restoring chemosensitivity.

Main Methods:

  • Transfection of p53-null osteosarcoma Saos-2 cells with the mutant p53 R175H construct.
  • Treatment of transfected cells with chemotherapeutic agents (doxorubicin, cisplatin) and gamma radiation.
  • Analysis of apoptosis induction, caspase-3, -8, and -9 protein levels, and procaspase-3 activation.
  • Gene silencing of p53 R175H using small interfering RNA (siRNA).

Main Results:

  • Transfection with p53 R175H suppressed apoptosis induced by doxorubicin, cisplatin, and gamma radiation in Saos-2 cells.
  • Downregulation of basal caspase-3 protein levels was observed in cells expressing p53 R175H.
  • p53 R175H expression significantly reduced doxorubicin-induced procaspase-3 activation, and gene silencing restored apoptosis.
  • The p53 R175H mutation appears to gain a new function that inhibits apoptosis by suppressing caspase-3 activation.

Conclusions:

  • The p53 R175H mutation confers a gain-of-function that impairs the apoptotic response to DNA damage in tumor cells.
  • This impaired apoptosis is mediated, at least in part, by the suppression of caspase-3 activation.
  • Targeting the mutant p53 R175H, for example, through gene silencing, can restore sensitivity to chemotherapy, highlighting its potential as a therapeutic strategy.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...